Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Roche's Tecentriq ready to compete in lung cancer
BioPharma Dive
Fri, 09/2/16 - 09:36 am
Roche
Tecentriq
non-small cell lung cancer
Roche launches next-gen glucose monitor
Mass Device
Wed, 08/24/16 - 05:41 pm
Roche
devices
diabetes
blood glucose monitoring
Roche, Eleven Bio eye the ocular market
BioPharma Dive
Fri, 08/19/16 - 11:48 am
Roche
Eleven Biotherapeutics
EBI-031
interleukin-6
Can Eleven Biotherapeutics Keep Climbing With This Roche Deal?
24/7 Wall St
Wed, 08/17/16 - 10:40 am
Eleven Biotherapeutics
Roche
EBI-031
interleukin-6
R&D
The ‘don’t eat me’ antidote: GlaxoSmithKline, Roche and Novo back $86M startup in high-stakes CD47 showdown
Endpoints
Tue, 08/16/16 - 11:16 am
GSK
Roche
Novo Nordisk
Tioma Therapeutics
CD47
immuno-oncology
As doubts continue to fester, Inovio gets another shove as Roche exits collaboration
Endpoints
Wed, 08/3/16 - 10:09 am
Roche
Inovio
INO-1800
INO-5150
hepatitis B
Hey, wait a second. What about Roche’s PhIII hemophilia A drug?
Endpoints
Fri, 07/29/16 - 11:24 am
Roche
hemophilia A
Chugai
emicizumab
ACE910
A Look at Roche’s Potential Revenue Drivers
Market Realist
Tue, 07/26/16 - 11:21 am
Roche
Perjeta
Herceptin
Kadcyla
Facing thousands of Accutane claims, Roche wins appeal of $18M jury verdict
Fierce Pharma
Mon, 07/25/16 - 11:20 am
Roche
Accutane
Galderma licenses PhII atopic dermatitis drug from Roche’s Chugai
Fierce Biotech
Fri, 07/22/16 - 11:47 am
Galderms
atopic dermatitis
Roche
Chugai
nemolizumab
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
WSJ Online
Fri, 07/22/16 - 09:49 am
Amgen
Allergan
biosimilars
Herceptin
ABP 980
Roche
breast cancer
Roche sales buoyed by cancer drugs
BioPharma Dive
Thu, 07/21/16 - 09:15 pm
Roche
earnings
Late-stage study of Roche's Gazyva in large B-cell lymphoma fails to hit main goal
First Word Pharma
Mon, 07/18/16 - 10:55 am
Roche
Gazyva
large B-cell lymphoma
clinical trials
The 15 top R&D spenders in the global biopharma business
Endpoints
Fri, 07/15/16 - 10:23 am
R&D
Roche
JNJ
Novartis
Pfizer
Merck
Bristol-Myers Squibb
BioMarin Pharmaceutical shares rise after possible takeover from Roche
CNBC
Thu, 07/7/16 - 04:02 pm
Biomarin
M&A
Roche
The World's 12 Most Reputable Pharmaceutical Companies In 2016
Forbes
Sat, 07/2/16 - 12:28 pm
Bayer
Abbott Labs
Novo Nordisk
Roche
Merck
Epizyme partners with Roche to test cancer drug combo
BioPharma Dive
Thu, 06/23/16 - 08:22 pm
Epizyme
Roche
PDL-1 inhibitors
diffuse large B-cell lymphoma
Tecentriq
tazemetostat
Pharm Exec's Top 50 Companies 2016
PharmExec
Mon, 06/20/16 - 09:24 am
Pfizer
Novartis
Roche
Merck
Sanofi
Gilead Sciences
JNJ
GSK
The World's 12 Most Reputable Pharmaceutical Companies In 2016
Forbes
Tue, 06/7/16 - 12:11 pm
public opinion
reputation
Bayer
Abbott Labs
Novo Nordisk
Roche
Drug makers pay $67m for misleading docs about cancer drug survival data
Stat
Mon, 06/6/16 - 11:21 pm
Roche
Genentech
OSI Pharmaceuticals
False Claims Act
whistleblower lawsuits
Tarceva
non-small cell lung cancer
Pages
« first
‹ previous
…
56
57
58
59
60
61
62
63
64
…
next ›
last »